Application Nr Approved Date Route Status External Links
NDA021703 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Prismasol And Phoxillum Solutions Are Indicated In Pediatric And Adult Patients For Use As A Replacement Solution In Continuous Renal Replacement Therapy (Crrt) To Replace Plasma Volume Removed By Ultrafiltration And To Correct Electrolyte And Acid-Base Imbalances. They May Also Be Used In Case Of Drug Poisoning When Crrt Is Used To Remove Dialyzable Substances. Prismasol And Phoxillum Solutions Are Indicated: • As A Replacement Solution In Continuous Renal Replacement Therapy (Crrt) And In Case Of Drug Poisoning When Crrt Is Used To Remove Dialyzable Substances ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 6 Total)

Name Structure ZINC ID(s)
1. Dextrose Monohydrate
2. Lactic Acid, Unspecified Form
3. Magnesium Chloride
4. Potassium Chloride
5. Sodium Bicarbonate SODIUM BICARBONATE ZINC6827693
6. Sodium Chloride

Comments